Find your next paid study

University of Colorado, DenverNCT07668622

Actual pay is set by the research site.

I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

I3LUNG is an international project aiming to develop a medical device to predict immunotherapy efficacy for NSCLC patients using the integration of multisource…

Non Small Cell Lung CancerLung Cancer MetastaticLung Cancer, Nonsmall Cell+1 more

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoNCT05537922

~$10 – $1,125

Actual pay is set by the research site.

Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease …

Hidradenitis Suppurativa

University of California, San FranciscoNCT04115566

~$10 – $675

Actual pay is set by the research site.

Observational

Cognitive Behavioral Therapy for Insomnia in Older African American Adults

Sleep problems, like insomnia, are common in older African Americans. About 25% of older adults in the US have at least 2 symptoms of insomnia, such as having …

Older Adults (65 Years and Older)

Rutgers, The State University of New JerseyNCT06791356

Actual pay is set by the research site.

Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A Phase Ib Multicenter, Open-label Study to Evaluate the Safety and Tolerability of Trastuzumab Deruxtecan (T-DXd) and Immunotherapy Agents With and Without Chemotherapy Agents in First-line Treatment of Patients With Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) and Human Epidermal Growth Factor Receptor 2 (HER2) Overexpression (OE) (DESTINY-Lung03)

DESTINY-Lung03 will investigate the safety and tolerability of trastuzumab deruxtecan in combination with Immunotherapy Agents with and without chemotherapy in…

~$150 – $4,500

Actual pay is set by the research site.

AstraZenecaNCT04686305

Observational

Shared Decision Making for Patients With Minor Head Injury: The "Concussion or Brain Bleed" Trial

Researchers are trying to understand the effect of educating patients and encouraging shared decision making on rates of CT scanning in head injured patients b…

Head Injury

Actual pay is set by the research site.

Mayo ClinicNCT04002505

Prostate Cancer (Adenocarcinoma)

High Dose Rate Brachytherapy Prior to Robotic Assisted Laparoscopic Prostatectomy With Selective Adjuvant Androgen Blockade for Localized High-risk Prostate Cancer (NEOHDR-B)

This is a Phase I/II trial evaluating the effectiveness of adding neoadjuvant HDR-B prior to RALP for HR-PCa patients with selective AAB for decipher high risk…

The Methodist Hospital Research InstituteNCT07182279

~$150 – $3,000

Actual pay is set by the research site.

The Myelin Disorders Biorepository Project and Global Leukodystrophy Initiative Clinical Trials Network

The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to s…

LeukodystrophyWhite Matter DiseaseLeukoencephalopathies+63 more

Observational

A Stage 1 Pilot Test for Feasibility and Efficacy of a Multi-Level Intervention to Increase Physical Activity in Adults With Intellectual Disability: Physical Activity and Community EmPOWERment (PACE)

Purpose: Conduct a wait-list randomized controlled trial (RCT) of an inclusive physical activity program called PACE for adults with intellectual disability (I…

Intellectual DisabilityNeurodevelopmental DisordersAutism Spectrum Disorder+10 more

University of North Carolina, Chapel Hill

Actual pay is set by the research site.

Locally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Sarcomatoid Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+3 more

Phase I/II Trial of Inulin Gel in Combination With Ipilimumab and Nivolumab in Advanced Renal Cell Carcinoma [ICON Trial]

This phase I/II trial tests the safety and effectiveness of inulin gel in combination with ipilimumab and nivolumab in treating patients with kidney cell cance…

University of Michigan Rogel Cancer CenterNCT06866262

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC)

This is a multicenter, single arm Phase 2B study in subjects with locally advanced oral cavity squamous cell carcinoma (OCSCC) with surgically resectable disea…

Oral Cavity Squamous Cell CarcinomaHead and Neck Cancer

UNC Lineberger Comprehensive Cancer CenterNCT07484139

~$75 – $2,000

Actual pay is set by the research site.

Advanced Hepatocellular Carcinoma

A Phase 1/2 Exploratory Study of the TBL1 Inhibitor, Tegavivint (BC2059), in Patients With Advanced Hepatocellular Carcinoma

This study will be conducted in 2 parts. The first part is a phase 1 single-agent dose escalation, and dose optimization, study of tegavivint in patients with …